RecruitingNCT03854318
Longitudinal Studies of Patient With FPDMM
Studying Familial platelet disorder with associated myeloid malignancy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Human Genome Research Institute (NHGRI)
- Principal Investigator
- Paul Liu, M.D.National Human Genome Research Institute (NHGRI)
- Enrollment
- 1000 enrolled
- Eligibility
- 100 years · All sexes
- Timeline
- 2019 – 2028
Study locations (1)
- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03854318 on ClinicalTrials.govOther trials for Familial platelet disorder with associated myeloid malignancy
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06261060Low-Dose Sirolimus to Increase Hematopoietic Function in Patients With RUNX1 Familial Platelet DisorderM.D. Anderson Cancer Center
- RECRUITINGPHASE1NCT06414889Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet DisorderM.D. Anderson Cancer Center
See all trials for Familial platelet disorder with associated myeloid malignancy →